Ascendis Pharma A ASND
NASDAQ ASND
$238.90 +4.57 (+1.95%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Gross Margin (2021 - 2026)

Updated

Ascendis Pharma A (ASND) reported Gross Margin of 91.85% for the quarter ended Jun 30, 2026, up 11.75 percentage points from 80.10% a year earlier but down 1.05 percentage points from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Gross Margin (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Gross Margin came in at 91.30%, up 6.51 percentage points year-over-year; for the year ended Dec 31, 2025, it was 86.82%, down 1.90 percentage points from the prior year.

  • Gross Margin has a five-year change of -13.18 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, Gross Margin came in at 88.72% in the year ended Dec 31, 2024 (+5.36 pp), 83.36% in the year ended Dec 31, 2023 (+7.07 pp), 76.28% in the year ended Dec 31, 2022 (+21.58 pp) and 54.71% in the year ended Dec 31, 2021 (-45.29 pp).
  • Five-year quarterly Gross Margin spans a low of 1.60% in the quarter ended Dec 31, 2021 and a high of 100.00% in the quarter ended Sep 30, 2021.
  • Year over year, Gross Margin gained in five of the last eight quarters, with an average year-over-year change of +10.10 percentage points.
  • The high point for year-over-year Gross Margin in five years was the quarter ended Dec 31, 2022 (a gain of 76.08 percentage points); the low point was the quarter ended Mar 31, 2022 (a drop of 62.19 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 92.90% (quarter ended Mar 31, 2026), 90.47% (quarter ended Dec 31, 2025) and 89.54% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 68.19%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 74.74%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 73.54%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 78.02%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 83.60%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 72.04%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 79.76%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 72.78%
10 Ascendis Pharma A 14.48 Bn 10.74 Bn 362.22 Mn 91.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 91.85%
Mar 31, 2026 92.90%
Dec 31, 2025 90.47%
Sep 30, 2025 89.54%
Jun 30, 2025 80.10%
Mar 31, 2025 82.65%
Dec 31, 2024 91.94%
Sep 30, 2024 80.63%
Jun 30, 2024 68.15%
Mar 31, 2024 92.11%
Dec 31, 2023 85.87%
Sep 30, 2023 84.62%
Jun 30, 2023 72.72%
Mar 31, 2023 86.24%
Dec 31, 2022 77.67%
Sep 30, 2022 88.93%
Jun 30, 2022 82.37%
Mar 31, 2022 37.81%
Dec 31, 2021 28.06%
Sep 30, 2021 100.00%
API Access

Ascendis Pharma A Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ASND&period=max&api_key=YOUR_API_KEY